Intervacc's distribution partner Dechra launches Strangvac in Spain, Portugal and Slovenia

Intervacc AB announces that its distribution partner, Dechra Pharmaceuticals, is launching the Strangvac vaccine in Spain, Portugal, and Slovenia. This vaccine, which protects against the contagious equine disease strangles, is already approved in the EU and has been launched in several other European countries. CEO Jonas Sohlman emphasizes the importance of this launch for animal health in the equine industry. Strangvac is developed using innovative technology and is part of Intervacc's commitment to improving animal health across Europe.